Hemorrhage Risk Among Patients With Breast Cancer Receiving Concurrent Direct Oral Anticoagulants With Tamoxifen vs Aromatase Inhibitors
Author(s) -
TzuFei Wang,
Anna E. Clarke,
Arif Awan,
Peter Tanuseputro,
Marc Carrier,
Manish M. Sood
Publication year - 2022
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2022.19128
Subject(s) - medicine , tamoxifen , breast cancer , apixaban , rivaroxaban , retrospective cohort study , population , cancer , aromatase inhibitor , oncology , warfarin , atrial fibrillation , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom